B2M and viral infectious disease: We may speculate that shared pathogenetic mechanisms in response to neurotropic viral infections (e.g., herpesviridae) may contribute to Aβ amyloid deposition in AD patients without HIV-1 and that neuroinflammation due to β2m release in patients with unstable HLA-C alleles may accelerate this phenomenon.